Last verified by NonDilute: 2026-04-29. Official notices and agency instructions control.
AI startups should monitor NSF, DoD, DARPA, NASA, DOE, and agency-specific mission pages. The best fit usually depends on the mission context: autonomy, scientific computing, defense, cybersecurity, space operations, health, or energy systems.
Current filtered records
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
NIDA is funding research to identify genetic and genomic variants underlying substance use disorders (SUD), addictive behaviors, and related comorbidities in animal models. The pro…
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required)
The NIH K25 award supports early-career researchers with quantitative backgrounds (math, statistics, computer science, physics, etc.) to transition their expertise into health and …
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
This NIH grant funds development of digital health technology (DHT)-derived biomarkers and clinical outcomes for use as endpoints in remote monitoring clinical trials. Applicants m…
Open Data Framework
This funding builds secure data repositories and cooperatives where farmers, universities, and nonprofits can store and share agricultural data to drive innovation and profitabilit…
Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
NIH funding to characterize how individual genetic variants affect genome function and phenotype through systematic research. Clinical trials are explicitly not permitted under thi…
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)
The NIH K25 award provides funding and protected time for scientists with quantitative backgrounds (math, statistics, CS, physics, etc.) to transition their expertise into health-f…
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
The FDA is funding research to assess real-world clinical outcomes when patients switch between generic and brand-name complex drug products. This U01 grant supports algorithmic an…
Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
FDA funding to support outsourcing facilities that produce drugs in short supply while implementing fraud prevention measures. The goal is to reduce barriers and increase capacity …
Public-source funding discovery only. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.